Want to see IN:MANGALAM full AI Analyst Report?
Total Valuation
Mangalam Drugs & Organics Ltd. has a market cap or net worth of ₹459.02M. The enterprise value is ₹1.55B.
Market Cap₹459.02M
Enterprise Value₹1.55B
Share Statistics
Mangalam Drugs & Organics Ltd. has 15,828,248 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding15,828,248
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Mangalam Drugs & Organics Ltd.’s return on equity (ROE) is -0.43 and return on invested capital (ROIC) is -14.06%.
Return on Equity (ROE)-0.43
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-14.06%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee7.28M
Profits Per Employee-1.39M
Employee Count319
Asset Turnover0.74
Inventory Turnover2.03
Valuation Ratios
The current PE Ratio of Mangalam Drugs & Organics Ltd. is ―. Mangalam Drugs & Organics Ltd.’s PEG ratio is 0.00127.
PE Ratio―
PS Ratio0.19
PB Ratio0.42
Price to Fair Value0.42
Price to FCF-2.07
Price to Operating Cash Flow6.05
PEG Ratio0.00127
Income Statement
In the last 12 months, Mangalam Drugs & Organics Ltd. had revenue of 2.32B and earned -444.00M in profits. Earnings per share was -28.05.
Revenue2.32B
Gross Profit232.46M
Operating Income-331.26M
Pretax Income-485.71M
Net Income-444.00M
EBITDA-149.03M
Earnings Per Share (EPS)-28.05
Cash Flow
In the last 12 months, operating cash flow was 77.10M and capital expenditures -57.97M, giving a free cash flow of 19.14M billion.
Operating Cash Flow77.10M
Free Cash Flow19.14M
Free Cash Flow per Share1.21
Dividends & Yields
Mangalam Drugs & Organics Ltd. pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.28%
Dividend Per Share₹0.5
Dividend Yield0.28%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-59.78%
50-Day Moving Average29.76
200-Day Moving Average30.63
Relative Strength Index (RSI)41.18
Average Volume (3m)12.40K
Important Dates
Mangalam Drugs & Organics Ltd. upcoming earnings date is Nov 14, 2026, TBA (Confirmed).
Last Earnings DateAug 12, 2026
Next Earnings DateNov 14, 2026
Ex-Dividend Date―
Financial Position
Mangalam Drugs & Organics Ltd. as a current ratio of 0.79, with Debt / Equity ratio of 0.00%
Current Ratio0.79
Quick Ratio0.27
Debt to Market Cap2.37
Net Debt to EBITDA-7.03
Interest Coverage Ratio-2.04
Taxes
In the past 12 months, Mangalam Drugs & Organics Ltd. has paid -41.71M in taxes.
Income Tax-41.71M
Effective Tax Rate0.09
Enterprise Valuation
Mangalam Drugs & Organics Ltd. EV to EBITDA ratio is -9.91, with an EV/FCF ratio of -7.10.
EV to Sales0.64
EV to EBITDA-9.91
EV to Free Cash Flow-7.10
EV to Operating Cash Flow-16.58
Balance Sheet
Mangalam Drugs & Organics Ltd. has ₹7.51M in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹7.51M billion.
Cash & Marketable Securities₹7.51M
Total Debt₹0.00
Net Cash₹7.51M
Net Cash Per Share₹0.47
Tangible Book Value Per Share₹44.27
Margins
Gross margin is 12.33%, with operating margin of -14.27%, and net profit margin of -19.13%.
Gross Margin12.33%
Operating Margin-14.27%
Pretax Margin-20.92%
Net Profit Margin-19.13%
EBITDA Margin-6.42%
EBIT Margin-14.27%
Analyst Forecast
The average price target for Mangalam Drugs & Organics Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-22.27%
EPS Growth Forecast-291.72%